Cocrystal Pharma, Inc. Balance Sheet
COCP|4 years of annual SEC 10-K data (FY2012-FY2021)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
Cocrystal Pharma, Inc. had $79M in total assets and $78M in shareholders' equity as of FY2021.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 | FY2020 | FY2019 | FY2012 |
|---|---|---|---|---|
| Cash & Equivalents | $58.7M | $33.0M | - | $4.7M |
| Accounts Receivable | - | $556.0K | $644.0K | $835.0K |
| Inventory | - | - | - | $1.7M |
| Current Assets | $59.3M | $34.0M | $8.3M | $6.7M |
| PP&E (Net) | $453.0K | $591.0K | $431.0K | $552.6K |
| Goodwill | $19.1M | $19.1M | $65.2M | $1.0M |
| Total Assets | $79.4M | $54.2M | $28.5M | $7.2M |
| Current Liabilities | $1.5M | $1.4M | $2.3M | $10.8M |
| Shareholders' Equity | $77.5M | $25.7M | $66.9M | -$5.0M |